Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors with Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033

IMPORTANCE: Initial results of this intergroup trial of imatinib for patients with metastatic/ unresectable GIST were reported in 2008 (http://www.ncbi.nlm.nih.gov/pubmed/18235122). Updated results reported here show long-term survival with a significant subset of patients surviving 10 or more years...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Heinrich, Michael C., Rankin, Cathryn, Blanke, Charles D., Demetri, George D., Borden, Ernest C., Ryan, Christopher W., von Mehren, Margaret, Blackstein, Martin E., Priebat, Dennis A., Tap, William D., Maki, Robert G., Corless, Christopher L., Fletcher, Jonathan A., Owzar, Kouros, Crowley, John J., Benjamin, Robert S., Baker, Laurence H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727908/
https://ncbi.nlm.nih.gov/pubmed/28196207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.6728
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados